Gold prices steady near $3,400/oz as Sept rate cut bets rise; econ. data awaited
Investing.com -- Materialise NV (NASDAQ:MTLS), a provider of additive manufacturing and medical software solutions, reported second quarter earnings on Thursday that missed analyst expectations despite stronger-than-expected revenue, as unfavorable exchange rate fluctuations significantly impacted the company’s bottom line.
The company reported second quarter earnings per share of $0.00, missing the analyst consensus estimate of $0.02. Revenue came in at $75.98 million, surpassing the consensus estimate of $67.21 million, though representing a 5.8% decrease compared to the same period last year.
Materialise’s Medical (TASE:BLWV) segment showed strong performance with 16.7% growth compared to the second quarter of 2024, while the Manufacturing segment declined 24.9% and the Software (ETR:SOWGn) segment fell 12.1% YoY.
"Our Materialise Medical segment once again demonstrated its resilience, growing by almost 17% compared to the same period of 2024," said CEO Brigitte de Vet-Veithen.
"At the same time increasing geo-political uncertainty and sustained macro-economic headwinds negatively impacted revenues in our Materialise Manufacturing and Materialise Software segments."
Despite revenue pressure, the company improved its gross profit margin to 58.3% from 57.0% in the prior-year period. Adjusted EBIT was €3.06 million for the quarter, down from €3.87 million in the second quarter of 2024, with adjusted EBIT margin declining to 4.7% from 5.6%.
Looking ahead, Materialise reduced its full-year revenue guidance to a range of €265-280 million, citing geopolitical volatility and macroeconomic uncertainty. However, the company maintained its adjusted EBIT guidance of €6-10 million for fiscal year 2025.
The company reported a net cash position of €63.05 million as of June 30, 2025, an increase of €2.03 million compared to December 31, 2024, driven by positive free cash flow during the first half of the year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.